Document Detail


Anesthetic considerations in premature birth.
MedLine Citation:
PMID:  1967245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Premature birth still accounts for about 75% of perinatal mortality. Although great strides have been made in the care of premature babies over the past two decades, markedly decreasing mortality, the prevention of premature birth has not been greatly improved. Although tocolysis, particularly with the beta-2 agonists and magnesium sulfate, may delay birth and allow fetal maturation, it poses several risks which, if not recognized, can cause serious morbidity and even mortality. The use of these drugs and other less widely used tocolytics has important implications for the anesthesiologist. The premature infant itself is subjected to such risks as RDS, IVH, NEC, asphyxia, hypothermia, increased incidence of breech presentation, metabolic disturbances, and predisposition for trauma. To ensure safe delivery, premature babies should be delivered in a tertiary care center equipped and ready to attend to their needs. Major conduction block, particularly continuous lumbar epidural analgesia, is an ideal form of analgesia for the delivery of most premature neonates. Properly administered, it maintains maternal physiology, is not associated with drug depression in the newborn, enables a controlled, atraumatic vaginal delivery, and has little interaction with tocolytics (and indeed may protect against some of their side effects). It is ideal for a trial of labor and, if initiated early, allows for an emergency cesarean section. Continuous lumbar epidural block and subarachnoid block are both superb for elective or urgent cesarean section. However, when their use is contraindicated, inhalation analgesia for vaginal delivery or general anesthesia for cesarean section can be safely administered from the standpoint of both mother and child. Expertly administered anesthesia is not a luxury but is indeed indispensable for successful premature delivery.
Authors:
B B Gutsche; P Samuels
Related Documents :
24522325 - Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: a...
7088435 - Squamous cell carcinoma metastatic to placenta and ovary.
23112915 - Low zinc status and absorption exist in infants with jejunostomies or ileostomies which...
12519045 - The effect of delivery on umbilical arterial cord blood gases and lipid peroxides: comp...
17032445 - Foetal and neonatal alloimmune thrombocytopaenia.
6998695 - Supplemental stimulation of preterm neonates.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International anesthesiology clinics     Volume:  28     ISSN:  0020-5907     ISO Abbreviation:  Int Anesthesiol Clin     Publication Date:  1990  
Date Detail:
Created Date:  1990-02-21     Completed Date:  1990-02-21     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0370760     Medline TA:  Int Anesthesiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  33-43     Citation Subset:  IM    
Affiliation:
Department of Anesthesia, Medical Center of the University of Pennsylvania, Philadelphia 19104.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / adverse effects,  therapeutic use
Anesthesia, Obstetrical*
Delivery, Obstetric
Female
Humans
Infant, Newborn
Infant, Premature / physiology
Magnesium Sulfate / adverse effects,  therapeutic use
Obstetric Labor, Premature*
Pregnancy
Tocolysis / methods
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  P-glycoproteins in pathology: the multidrug resistance gene family in humans.
Next Document:  Chronic anxiety: deciding the length of treatment.